Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
0.7676
+0.0249 (3.35%)
Aug 4, 2026, 11:12 AM EDT - Market open
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $2.68 million as of August 4, 2026. Its market cap has decreased by -62.76% in one year.
Market Cap
2.68M
Enterprise Value
-6.97M
1-Year Change
-62.76%
Ranking
Category
Stock Price
$0.77
ChartMarket Cap Chart
Since November 14, 2017, Artelo Biosciences's market cap has decreased from $5.88M to $2.68M, a decrease of -54.46%. That is a compound annual growth rate of -8.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 2.68M | 8.63% |
| Dec 31, 2025 | 2.46M | -28.01% |
| Dec 31, 2024 | 3.42M | -23.37% |
| Dec 29, 2023 | 4.46M | -45.90% |
| Dec 30, 2022 | 8.25M | -62.41% |
| Dec 31, 2021 | 21.95M | 99.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 60 Degrees Pharmaceuticals | 3.11M |
| Onconetix | 3.05M |
| Genprex | 2.88M |
| Clearmind Medicine | 2.51M |
| Creative Medical Technology Holdings | 2.45M |
| GRI Bio | 2.44M |
| Propanc Biopharma | 2.30M |
| Oragenics | 2.26M |